The Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice.

Varghese, Merilyn S; Liu, Chia-Liang; Kazi, Dhruv S

Varghese, Merilyn S; Liu, Chia-Liang; Kazi, Dhruv S.

Afiliação

Varghese MS; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, 375 Longwood Ave, 4th Floor, Boston, MA, 02215, USA.
Liu CL; Harvard Medical School, Boston, MA, USA.
Kazi DS; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, 375 Longwood Ave, 4th Floor, Boston, MA, 02215, USA.

Curr Cardiol Rep ; 23(11): 163, 2021 10 01.

Article em En | MEDLINE | ID: mdl-34599393

Assuntos

Fármacos Cardiovasculares; Fármacos Cardiovasculares/uso terapêutico; Análise Custo-Benefício; Custos de Medicamentos; Humanos

Palavras-chave

Adherence; Cardiovascular; Cost-effectiveness; Drug pricing; Orphan drugs; Out-of-pocket costs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google